Company profile for Strand Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics. This area was untapped by traditional synthetic biology, which led them to build their own mRNA “programming language,” creating the world’s first platform for mRNA smart therapi...
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics. This area was untapped by traditional synthetic biology, which led them to build their own mRNA “programming language,” creating the world’s first platform for mRNA smart therapies.The programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body using mRNA-encoded.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Kendall Square, Binney St, Cambridge, Massachusetts 02139
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251215101222/en/Strand-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

BUSINESSWIRE
15 Dec 2025

https://www.businesswire.com/news/home/20251202898116/en/Strand-Therapeutics-Appoints-Jeb-Keiper-to-Board-of-Directors

BUSINESSWIRE
02 Dec 2025

https://www.businesswire.com/news/home/20251105520833/en/Strand-Therapeutics-Promotes-Prashant-Nambiar-to-Chief-Scientific-Officer-and-Appoints-Ethan-Cash-as-Senior-Vice-President-Head-of-Portfolio-Management-and-Program-Development

BUSINESSWIRE
05 Nov 2025

https://www.businesswire.com/news/home/20250821223254/en/Strand-Therapeutics-Appoints-Dr.-Jason-J.-Luke-as-Chief-Medical-Officer

BUSINESSWIRE
21 Aug 2025

https://www.biospace.com/business/big-pharma-backed-mrna-startup-bags-153m-series-b-amid-policy-headwinds

BIOSPACE
07 Aug 2025

https://www.businesswire.com/news/home/20250528368906/en/Strand-Therapeutics-Announces-Initial-First-in-human-Phase-1-Data-for-STX-001-in-Patients-with-Advanced-Solid-Tumors-at-The-2025-ASCO-Annual-Meeting

BUSINESSWIRE
28 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty